We provide you with 20 years of free, institutional-grade data for AEZS stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of AEZS. Explore the full financial landscape of AEZS stock.
| Reported Date | CIK | Ticker | Type |
|---|
Aeterna Zentaris Inc(NASDAQ:AEZS) 
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, a peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a fo...
Website: http://www.zentaris.com
Founded: 1990
CEO: David Mazzo
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about AEZS stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.